TSX:DR - 애널리스트의 미래 추정치 및 과거 재무 데이터 (USD Millions )
날짜	수익	수익	잉여 현금 흐름	작전 현금	평균 애널리스트 수
12/31/2026	340	N/A	N/A	N/A	1
12/31/2025	338	13	N/A	N/A	2
12/31/2024	428	19	N/A	N/A	2
9/30/2024	441	20	74	81	N/A
6/30/2024	442	12	59	75	N/A
3/31/2024	445	16	63	78	N/A
12/31/2023	446	19	57	73	N/A
9/30/2023	443	5	52	70	N/A
6/30/2023	440	-5	58	68	N/A
3/31/2023	433	8	56	64	N/A
12/31/2022	425	-4	50	57	N/A
9/30/2022	416	8	58	63	N/A
6/30/2022	410	15	58	64	N/A
3/31/2022	405	4	59	67	N/A
12/31/2021	399	16	67	76	N/A
9/30/2021	395	2	67	75	N/A
6/30/2021	395	9	76	85	N/A
3/31/2021	365	4	112	118	N/A
12/31/2020	364	11	106	113	N/A
9/30/2020	371	36	101	109	N/A
6/30/2020	371	39	93	103	N/A
3/31/2020	397	62	61	72	N/A
12/31/2019	398	44	65	77	N/A
9/30/2019	367	31	63	78	N/A
6/30/2019	374	28	62	79	N/A
3/31/2019	387	11	59	80	N/A
12/31/2018	391	23	60	81	N/A
9/30/2018	420	23	63	83	N/A
6/30/2018	404	18	N/A	79	N/A
3/31/2018	394	25	N/A	85	N/A
12/31/2017	385	21	N/A	80	N/A
9/30/2017	382	38	N/A	79	N/A
6/30/2017	372	35	N/A	88	N/A
3/31/2017	353	15	N/A	76	N/A
12/31/2016	339	10	N/A	78	N/A
9/30/2016	321	-5	N/A	82	N/A
6/30/2016	316	6	N/A	72	N/A
3/31/2016	312	9	N/A	82	N/A
12/31/2015	309	25	N/A	80	N/A
9/30/2015	301	8	N/A	84	N/A
6/30/2015	303	22	N/A	88	N/A
3/31/2015	300	39	N/A	86	N/A
12/31/2014	297	19	N/A	88	N/A
9/30/2014	305	33	N/A	92	N/A
6/30/2014	303	17	N/A	90	N/A
3/31/2014	306	9	N/A	84	N/A
12/31/2013	309	11	N/A	86	N/A

애널리스트 미래 성장 예측

수입 대 저축률: DR 의 수익은 향후 3년간 감소할 것으로 예상됩니다(연간 -30% ).

수익 vs 시장: DR 의 수익은 향후 3년간 감소할 것으로 예상됩니다(연간 -30% ).

고성장 수익: DR 의 수익은 향후 3년간 감소할 것으로 예상됩니다.

수익 대 시장: DR 의 수익은 향후 3년간 감소할 것으로 예상됩니다(연간 -14.3% ).

고성장 수익: DR 의 수익은 향후 3년 동안 감소할 것으로 예상됩니다(연간 -14.3% ).

주당 순이익 성장 예측

미래 자기자본 수익률

미래 ROE: DR 의 자기자본수익률이 3년 내에 높을 것으로 예상되는지 판단하기에는 데이터가 부족합니다.

성장 기업 발견

기업 분석 및 재무 데이터 현황

데이터	마지막 업데이트(UTC 시간)
기업 분석	2024/12/27 05:23
장 마감 주가	2024/12/27 00:00
수익	2024/09/30
연간 수익	2023/12/31

데이터 소스

기업 분석에 사용된 데이터는 S&P Global Market Intelligence LLC의 데이터입니다. 이 보고서를 생성하기 위해 분석 모델에 사용된 데이터는 다음과 같습니다. 데이터는 정규화되어 있으므로 소스가 제공되기까지 지연이 발생할 수 있습니다.

패키지	데이터	기간	미국 소스 예시 ^*
회사 재무	10년	손익 계산서 현금 흐름표 대차 대조표	SEC 양식 10-K SEC 양식 10-Q
애널리스트 컨센서스 추정치	+3년	재무 예측 애널리스트 목표가	애널리스트 연구 보고서 Blue Matrix
시장 가격	30년	주식 가격 배당금, 분할 및 액션	ICE 시장 데이터 SEC 양식 S-1
소유권	10년	최대 주주 내부자 거래	SEC 양식 4 SEC 양식 13D
관리	10년	리더십 팀 이사회	SEC 양식 10-K SEC 양식 DEF 14A
주요 개발 사항	10년	회사 공지 사항	SEC 양식 8-K

* 미국 증권의 경우, 미국 외 지역의 규제 양식 및 출처가 사용된 예입니다.

명시되지 않는 한 모든 재무 데이터는 1년을 기준으로 하지만 분기별로 업데이트됩니다. 이를 후행 12개월(TTM) 또는 최근 12개월(LTM) 데이터라고 합니다. 여기에서 자세히 알아보세요.

분석 모델 및 눈송이

이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 Github 페이지에서 확인할 수 있으며, 보고서 사용 방법에 대한 가이드와 튜토리얼도 유튜브에서 확인할 수 있습니다.

Simply 월스트리트 분석 모델을 설계하고 구축한 세계적인 수준의 팀에 대해 알아보세요.

산업 및 부문 메트릭

업계 및 섹션 지표는 Simply Wall St에서 6시간마다 계산되며, 자세한 내용은 확인할 수 있습니다.

애널리스트 출처

Medical Facilities Corporation 8 애널리스트 중 2 애널리스트가 보고서의 입력 자료로 사용된 매출 또는 수익 추정치를 제출했습니다. 애널리스트의 제출 자료는 하루 종일 업데이트됩니다.

분석가	교육기관
Neil Maruoka	Canaccord Genuity
Prakash Gowd	CIBC Capital Markets
Douglas Loe	Echelon Wealth Partners Inc.

Medical Facilities 미래 성장

Future 기준 확인 0/6

주요 정보

최근 미래 성장 업데이트

Consensus EPS estimates fall by 16%

Consensus EPS estimates increase by 32%

Medical Facilities Corporation Just Reported A Surprise Loss: Here's What Analysts Think Will Happen Next

Consensus forecasts updated

Consensus forecasts updated

Consensus forecasts updated

Recent updates

Third quarter dividend of CA$0.09 announced

Chief Financial Officer recently sold CA$127k worth of stock

Medical Facilities Corporation Announces Fourth Quarter Dividend, Payable on January 15, 2025

Independent Director recently sold CA$1.6m worth of stock

Sanford Health completed the acquisition of Black Hills Surgical Hospital, Llp from Medical Facilities Corporation (TSX:DR) for US $194 million

Sanford Health completed the acquisition of Black Hills Surgical Hospital, Llp from Medical Facilities Corporation (TSX:DR) for US $194 million

Consensus EPS estimates fall by 16%

New major risk - Revenue and earnings growth

Medical Facilities' (TSE:DR) Earnings Offer More Than Meets The Eye

Sanford Health entered into a definitive agreement to acquire Black Hills Surgical Hospital, Llp from Medical Facilities Corporation (TSX:DR) for US $194 million, subject to customary purchase price adjustments.

New minor risk - Earnings quality

Third quarter 2024 earnings: EPS and revenues miss analyst expectations

Medical Facilities Corporation to Report Q3, 2024 Results on Nov 07, 2024

Second quarter dividend of CA$0.09 announced

Second quarter 2024 earnings: EPS misses analyst expectations

Medical Facilities Corporation to Report Q2, 2024 Results on Aug 06, 2024

Medical Facilities (TSE:DR) Is Paying Out A Dividend Of $0.09

Medical Facilities Corporation Announces Second Quarter Dividend, Payable on July 15, 2024

Now 22% overvalued after recent price rise

First quarter 2024 earnings released: EPS: US$0.07 (vs US$0.17 in 1Q 2023)

Medical Facilities Corporation to Report Q1, 2024 Results on May 09, 2024

Fourth quarter dividend of CA$0.081 announced

We Think Medical Facilities' (TSE:DR) Robust Earnings Are Conservative

Consensus EPS estimates increase by 32%

Now 21% overvalued after recent price rise

Medical Facilities Corporation Announces First Quarter Cash Dividend, Payable on April 15, 2024

New major risk - Revenue and earnings growth

Full year 2023 earnings: EPS and revenues exceed analyst expectations

Medical Facilities Corporation, Annual General Meeting, May 09, 2024

Medical Facilities Corporation to Report Q4, 2023 Results on Mar 14, 2024

Now 22% overvalued after recent price rise

Medical Facilities Corporation Announces Fourth Quarter Cash Dividend, Payable on January 15, 2024

Medical Facilities Corporation Appoints Jason Redman as President

Medical Facilities Corporation Just Reported A Surprise Loss: Here's What Analysts Think Will Happen Next

Third quarter 2023 earnings: EPS misses analyst expectations

Medical Facilities Corporation to Report Q3, 2023 Results on Nov 09, 2023

Medical Facilities Corporation Announces Third Quarter Dividend, Payable on October 16, 2023

Second quarter 2023 earnings: EPS exceeds analyst expectations

Medical Facilities (TSE:DR) Seems To Use Debt Quite Sensibly

Medical Facilities Corporation to Report Q2, 2023 Results on Aug 10, 2023

Medical Facilities Corporation Announces Second Quarter Dividend, Payable on July 17, 2023

First quarter 2023 earnings released: EPS: US$0.17 (vs US$0.26 loss in 1Q 2022)

Medical Facilities' (TSE:DR) Dividend Will Be $0.0805

Full year 2022 earnings: EPS and revenues miss analyst expectations

Medical Facilities (TSE:DR) Has Affirmed Its Dividend Of $0.0805

Medical Facilities Corporation Announces Fourth Quarter Dividend, Payable on January 16, 2023

Consensus forecasts updated

Third quarter 2022 earnings: EPS misses analyst expectations

Third quarter 2022 earnings: EPS misses analyst expectations

Medical Facilities Corporation to Report Q3, 2022 Results on Nov 10, 2022

Medical Facilities Corporation Announces Executive Changes

Independent Director recently bought CA$1.1m worth of stock

Medical Facilities Corporation Announces Third Quarter Dividend, Payable on October 15, 2022

Medical Facilities Corporation (TSX:DR) announces an Equity Buyback for $34.5 million worth of its shares.

Is Medical Facilities (TSE:DR) Using Too Much Debt?

Consensus forecasts updated

Second quarter 2022 earnings: EPS and revenues exceed analyst expectations

Medical Facilities Corporation to Report Q2, 2022 Results on Aug 11, 2022

Medical Facilities Corporation Announces Second Quarter 2022 Dividend, Payable on July 15, 2022

Consensus forecasts updated

First quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Is It Too Late To Consider Buying Medical Facilities Corporation (TSE:DR)?

Medical Facilities Corporation Announces Changes to the Board of Directors of the Corporation

Insufficient new directors

The Returns At Medical Facilities (TSE:DR) Aren't Growing

Medical Facilities Corporation, Annual General Meeting, Jun 21, 2022

Medical Facilities Corporation Announces First Quarter 2022 Cash Dividend, Payable on April 14, 2022

Consensus forecasts updated

Full year 2021 earnings: EPS and revenues exceed analyst expectations